Studies to Assess Ziftomenib in Combination with Ven+Aza or 7+3 in Patients with Untreated NPM1-m or KMT2A-r AML
Clinical Trial Grant
Awarded By
Kura Oncology, Inc.
Start Date
October 14, 2025
End Date
October 31, 2030
Awarded By
Kura Oncology, Inc.
Start Date
October 14, 2025
End Date
October 31, 2030